marcus evans europe conferences

DIGITAL WEEK - 11th Annual Biologics Formulation Development and Drug Delivery

Foster the Stability and the Robustness of your Formulation Through all the Processes to Ensure a Safe Delivery to Patients

22-26 June 2020
Virtual - Online, Netherlands


Why You Should Attend

DIGITAL WEEK - 11th Annual Biologics Formulation Development and Drug Delivery

Our Digital Week Format

We recognise that in today’s worlds our clients need information delivered in a different way; one that recognises that fluid working hours and flexible working environments are the “new normal”. Our DIGITAL WEEK FORMAT is designed to compliment this new way of working by delivering three hours of highly focused, practitioner drive content per day, spread across your working week through our innovative Live+ online streaming platform.

Event Focus

This marcus evans event will provide attendees with a more coherent, efficient, and comprehensive view on the whole formulation process (from preformulation through to production, manufacturing, and delivery). They will benefit from case studies on major challenges such as aggregates, particles, bioavailability, immunogenicity, and compatibility; and will learn how to minimise risks, time, and expenditure.

Protein formulation development is a challenging process which ultimately determines the effectiveness and profitability of the final protein drug. Proteins are complex and fragile molecules which are not easy to identify, comprehend, and most of all, to stabilise in the long term. These are the main parameters for a drug to be accepted by regulators and scientists also have to think one step ahead to look at the impacts of formulation on manufacturing and drug delivery. Besides the complexity of proteins, formulation needs to be robust and count on clear processes which can guarantee the quality of the product, reproducibility, efficacy in fighting against targeted cells, and stability throughout the whole process. Thanks to technical and analytical tools, protein formulation and process development is becoming more efficient. Drug deliveries and drug administration routes are also undergoing a process of innovation.

marcus evans Live+

Our passion is connecting people through our events; we firmly believe a virtual event experience should be no different. Our Live+ content platform will of course give you access to all the presentations as they happen and beyond, but we have to do much better than that! Our focus is on unlocking the incredible knowledge, experience and value within our entire event delegation, not just our world class speakers. That is why our Live + platform is loaded with features to ensure you are able to fully participate.

Insightful – Flexible – Impactful

 


Key Topics

  • Sanofi Pasteur explore how to optimise formulation and stability prediction for biologics
  • Coriolis Pharma examine the challenges of measuring aggregation and conformational changes for biologics
  • Janssen address challenges around the formulation and stability of non-protein biological molecules
  • Queen’s University Belfast explain how 3D printed devices can improve biopharmaceutical drug delivery
  • Previous Attendees Include

    • GlaxoSmithKline
    • Pfizer
    • Abbvie
    • Roche Biologics
    • UCB
    • Sandoz
    • Abbott
    • Baxter
    • Novartis Vaccines
    • Sanofi aventis
    • Boehringer Ingelheim
    • Medimmune
    • Bayer
    • Bristol-Myers Squibb
    • Genentech
    • Janssen Pharmaceutical
    • Merck & Co
    • Novo Nordisk
    • University of Cambridge


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Carsten Worsøe
    Principal Scientist, Extractables and Leachables
    Novo Nordisk

    Jonas Fransson
    Director, Drug Product Development
    Swedish Orphan Biovitrum

    Yinan Chen
    Principal Scientist, Formulation Development
    Janssen

    Dimitrios Lamprou
    Reader in Pharmaceutical Engineering
    Queen’s University Belfast

    Joël Richard
    Chief Development Officer, Drug Development Operations
    Medincell

    Florie Schild
    BRD Europe – Formulation and Stability Unit
    Sanofi R&D

    Dr Driton Vllasaliu
    Lecturer in Pharmaceutics
    King’s College London

    Bernhard Valldorf
    Lab Head, Biologics Formulation Development
    Merck

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference was very interesting – all the topics presented have been very useful!”, Genzyme
    • “Really enjoyed the speakers & interactivity of the event!”, Ipsen
    • “One of the best meetings I’ve attended. Excellent organisation, topics and speakers”, GSK
    • “High quality agenda and fantastic speakers, I would definitely attend again”, Roche
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com